Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. E. Meijer

Research interests

Esther Meijer is an internist-nephrologist with specific interest in Autosomal Dominant Polycystic Kidney Disease (ADPKD). At the University Medical Center Groningen (UMCG), she combines clinical work with research. She sees approximately 250 ADPKD patients per year and is study coordinator of a Dutch national observational cohort of ADPKD patients. Her current research focuses on markers of disease progression, and improving treatment in ADPKD. In 2019, she received an early career grant from the Dutch Kidney Foundation to investigate improvement of treatment with a vasopressin V2 receptor antagonist, by decreasing the adverse events. 

Publications

Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD

Effects of salt and protein intake on polyuria in V2RA-treated ADPKD patients

Kidney phosphate wasting predicts poor outcome in polycystic kidney disease

Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease

Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease

The association of urinary epidermal growth factors with ADPKD disease severity and progression

The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease

The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients

Bleeding risk in patients with autosomal dominant polycystic kidney disease treated with acetylsalicylic acid: implications for prevention of preeclampsia

Read more